ArticleFrontiers in immunology2022

Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection.

Weizheng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.